arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

MeiraGTx Holdings plc

MGTX
$8.50 ▼ -0.92 (-9.77%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
38 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

MeiraGTx Holdings plc faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $777.1M
Dividend Yield —
Revenue Growth 8608.6%
Op. Margin 76.0%
ROIC None
FCF / Share $-0.43 ↘
Trailing P/E 4.8x
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

38-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$321.43M
↑ +8608.6% —
Net Income Profit after all expenses
$160.72M
↑ +447.0% —
Operating Margin Operating profit as % of sales
76.0%
↑ +116.5% 1th
FCF / Share Free cash flow per share
$-0.43
↓ -318.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
2
Financial Health ↑
32
Cash Quality ↓
37

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 10 years · 38 quarters